Prognostic Implications of Type and Density of Tumour-infiltrating Lymphocytes in Gastric Cancer

Overview

Journal Br J Cancer

Specialty Oncology

Date 2008 Oct 23

PMID 18941457

Citations 177

Authors

H E Lee

S W Chae

Y J Lee

M A Kim

H S Lee

B L Lee

W H Kim

Affiliations

Soon will be listed here.

Abstract

The study aims to determine whether type and density of tumour-infiltrating lymphocytes (TILs) can predict the clinical course in gastric cancer. Gastric carcinomas (n=220) were immunostained for CD3, CD8, CD20, and CD45RO and evaluated for clinicopathologic characteristics. Number of TILs that immunostained positively for each marker were counted using NIH ImageJ software. Tumours were grouped into low- and high-density groups for each marker (CD3, CD8, CD45RO). The densities of CD3(+), CD8(+), and CD45RO(+) TILs were found to be independent predictors of lymph node metastasis by multivariate analysis with odds ratios (95% CI) of 0.425 (0.204-0.885), 0.325 (0.150-0.707), and 0.402 (0.190-0.850), respectively. Kaplan-Meier survival analysis revealed that patients in the high-density groups for CD3, CD8, and C45RO had a significantly longer survival time than the patients in the corresponding low-density groups, respectively. In multivariate survival analysis, the densities of CD3(+), CD8(+), and CD45RO(+) TILs remained independent prognostic factors with hazard ratios (95% CI) of 0.549 (0.317-0.951), 0.574 (0.347-0.949), and 0.507 (0.298-0.862), respectively. In conclusion, density of TILs was found to be independently predictive of regional lymph node metastasis and patient survival in gastric cancer.

Citing Articles

Tumor infiltration of inactive CD8 + T cells was associated with poor prognosis in Gastric Cancer.

Katayama N, Ohuchida K, Son K, Tsutsumi C, Mochida Y, Noguchi S Gastric Cancer. 2024; 28(2):211-227.

PMID: 39722065 PMC: 11842491. DOI: 10.1007/s10120-024-01577-4.

The Role of Lymphocytic Infiltrates in the Tumor Microenvironment as a Predictive Factor for the Response to Immunotherapy in Solid Tumors: A Single-Center Experience From Romania.

Mihaila R, Gheorghe A, Zob D, Stanculeanu D Cureus. 2024; 16(11):e74194.

PMID: 39583615 PMC: 11582497. DOI: 10.7759/cureus.74194.

Causal relationship between circulating immune cells and gastric cancer: a bidirectional Mendelian randomization analysis using UK Biobank and FinnGen datasets.

Yang W, Ou Y, Luo H, You L, Du H Transl Cancer Res. 2024; 13(9):4702-4713.

PMID: 39430856 PMC: 11483344. DOI: 10.21037/tcr-24-480.

The Importance of Predictive Biomarkers and Their Correlation with the Response to Immunotherapy in Solid Tumors-Impact on Clinical Practice.

Mihaila R, Gheorghe A, Zob D, Stanculeanu D Biomedicines. 2024; 12(9).

PMID: 39335659 PMC: 11429372. DOI: 10.3390/biomedicines12092146.

Evaluation of immune-checkpoint molecules in dMMR/pMMR colorectal cancer by multiplex immunohistochemistry.

Naumov S, Tashireva L, Krakhmal N, Vtorushin S Clin Transl Oncol. 2024; .

PMID: 39240301 DOI: 10.1007/s12094-024-03691-2.

References

Ishigami S, Natsugoe S, Tokuda K, Nakajo A, Che X, Iwashige H . Prognostic value of intratumoral natural killer cells in gastric carcinoma. Cancer. 2000; 88(3):577-83. View

Sabbatini P, Odunsi K . Immunologic approaches to ovarian cancer treatment. J Clin Oncol. 2007; 25(20):2884-93. DOI: 10.1200/JCO.2007.11.0775. View

Hippo Y, Taniguchi H, Tsutsumi S, Machida N, Chong J, Fukayama M . Global gene expression analysis of gastric cancer by oligonucleotide microarrays. Cancer Res. 2002; 62(1):233-40. View

Fukuda K, Tsujitani S, Maeta Y, Yamaguchi K, Ikeguchi M, Kaibara N . The expression of RCAS1 and tumor infiltrating lymphocytes in patients with T3 gastric carcinoma. Gastric Cancer. 2002; 5(4):220-7. DOI: 10.1007/s101200200038. View

Zhang L, Conejo-Garcia J, Katsaros D, Gimotty P, Massobrio M, Regnani G . Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer. N Engl J Med. 2003; 348(3):203-13. DOI: 10.1056/NEJMoa020177. View

Mazumdar M, Smith A, Bacik J . Methods for categorizing a prognostic variable in a multivariable setting. Stat Med. 2003; 22(4):559-71. DOI: 10.1002/sim.1333. View

Ichihara F, Kono K, Takahashi A, Kawaida H, Sugai H, Fujii H . Increased populations of regulatory T cells in peripheral blood and tumor-infiltrating lymphocytes in patients with gastric and esophageal cancers. Clin Cancer Res. 2003; 9(12):4404-8. View

Dunn G, Old L, Schreiber R . The three Es of cancer immunoediting. Annu Rev Immunol. 2004; 22:329-60. DOI: 10.1146/annurev.immunol.22.012703.104803. View

Rosenberg S, Yang J, Restifo N . Cancer immunotherapy: moving beyond current vaccines. Nat Med. 2004; 10(9):909-15. PMC: 1435696. DOI: 10.1038/nm1100. View

10.

MING S . Gastric carcinoma. A pathobiological classification. Cancer. 1977; 39(6):2475-85. DOI: 10.1002/1097-0142(197706)39:6<2475::aid-cncr2820390626>3.0.co;2-l. View

11.

Engstrom P, Lavin P, Douglass Jr H, BRUNNER K . Postoperative adjuvant 5-fluorouracil plus methyl-CCNU therapy for gastric cancer patients. Eastern Cooperative Oncology Group study (EST 3275). Cancer. 1985; 55(9):1868-73. DOI: 10.1002/1097-0142(19850501)55:9<1868::aid-cncr2820550904>3.0.co;2-b. View

12.

Coombes R, Schein P, Chilvers C, Wils J, Beretta G, Bliss J . A randomized trial comparing adjuvant fluorouracil, doxorubicin, and mitomycin with no treatment in operable gastric cancer. International Collaborative Cancer Group. J Clin Oncol. 1990; 8(8):1362-9. DOI: 10.1200/JCO.1990.8.8.1362. View

13.

Goseki N, Takizawa T, Koike M . Differences in the mode of the extension of gastric cancer classified by histological type: new histological classification of gastric carcinoma. Gut. 1992; 33(5):606-12. PMC: 1379287. DOI: 10.1136/gut.33.5.606. View

14.

Clemente C, Mihm Jr M, Bufalino R, Zurrida S, Collini P, Cascinelli N . Prognostic value of tumor infiltrating lymphocytes in the vertical growth phase of primary cutaneous melanoma. Cancer. 1996; 77(7):1303-10. DOI: 10.1002/(SICI)1097-0142(19960401)77:7<1303::AID-CNCR12>3.0.CO;2-5. View

15.

Maehara Y, Tomisaki S, Oda S, Kakeji Y, Tsujitani S, Ichiyoshi Y . Lymph node metastasis and relation to tumor growth potential and local immune response in advanced gastric cancer. Int J Cancer. 1997; 74(2):224-8. DOI: 10.1002/(sici)1097-0215(19970422)74:2<224::aid-ijc15>3.0.co;2-d. View

16.

LAUREN P . THE TWO HISTOLOGICAL MAIN TYPES OF GASTRIC CARCINOMA: DIFFUSE AND SO-CALLED INTESTINAL-TYPE CARCINOMA. AN ATTEMPT AT A HISTO-CLINICAL CLASSIFICATION. Acta Pathol Microbiol Scand. 1965; 64:31-49. DOI: 10.1111/apm.1965.64.1.31. View

17.

Parkin D, Bray F, Ferlay J, Pisani P . Global cancer statistics, 2002. CA Cancer J Clin. 2005; 55(2):74-108. DOI: 10.3322/canjclin.55.2.74. View

18.

Chen C, Lin J, Chen J, Lee P, Yang C, Kuo M . Gene expression profile predicts patient survival of gastric cancer after surgical resection. J Clin Oncol. 2005; 23(29):7286-95. DOI: 10.1200/JCO.2004.00.2253. View

19.

Pages F, Berger A, Camus M, Sanchez-Cabo F, Costes A, Molidor R . Effector memory T cells, early metastasis, and survival in colorectal cancer. N Engl J Med. 2005; 353(25):2654-66. DOI: 10.1056/NEJMoa051424. View

20.

de Visser K, Eichten A, Coussens L . Paradoxical roles of the immune system during cancer development. Nat Rev Cancer. 2006; 6(1):24-37. DOI: 10.1038/nrc1782. View